InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Smither John W, 董事. Officer active across 5 companies, notably eFFECTOR Therapeutics, Inc.. Cumulatively, 12 disclosures have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €52k. History available since 11 September 2023. The latest transaction was filed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Smither John W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
1,600 股@ US$25.32Ordinary SharesSEC:0001193125-26-386508:0
28,000 股0Common StockSEC:0001193125-26-331642:0
28,409 股Common StockSEC:0001493152-26-029413:0
3,400 股Ordinary SharesSEC:0001193125-26-009270:0
22,283 股0Common StockSEC:0001641172-25-026005:0
6,960 股Ordinary SharesSEC:0000950170-25-003570:0
39,541 股0Common StockSEC:0001415889-24-020778:0
6,250 股Common StockSEC:0001415889-24-016109:0
标准退出：2024年8月27日 (T+90)
2,793 股Common StockSEC:0001787306-24-000014:0
900 股@ US$20.78100.0% 占其流量Common StockSEC:0001209191-23-049519:0
6,920 股0Common StockSEC:0001209191-23-049364:0
24,142 股Common StockSEC:0001209191-21-053707:0
12 条申报中的 12 条
About Smither John W
Smither John W is Administrateur. He has 11 filings in total, and in the recent filings available, the reported sell amount totals EUR 17423, with the first filing dated 2021-08-27 and the last dated 2026-08-04. The companies listed are GENELUX CORP, NewAmsterdam Pharma Co N.V., MBX Biosciences, Inc., Arcutis Biotherapeutics, Inc. and eFFECTOR Therapeutics, Inc.
